University of Greenwich
Professor Jeremy Everett is Professor of Pharmaceutical Technologies in the department of Pharmaceutical, Chemical & Environmental Sciences within the School of Science.
Professor Everett maintains a strong research interest in structure elucidation by NMR spectroscopy and in metabonomics. He conceived metabonomics, and named and defined it together with Professor Jeremy Nicholson (Imperial College, London), with whom he has a long-standing collaboration. He is a co-discoverer of pharmacometabonomics: which is the ability to predict the effects of drugs prior to dosing via metabolic profiling, and he is a co-inventor on a patent granted in the European Community on metabolic profiling in 2011. He is a Visiting Professor in the Department of Surgery and Cancer at Imperial College.
Professor Everett is a co-leader of the Medway Metabonomics Group(MMRG) together with Dr Ruey-Leng Loo from the School of Pharmacy and Professor Frank Pullen from the School of Science .
Professor Everett is the author of over 80 publications and reviews and a co-inventor on 3 patents, including one granted in Europe in 2011 on metabolic profiling. He has an H-index of 24 and has been cited in the literature over 2500 times, with his top 3 papers each cited over 300 times.
Professor Everett consults for both major pharmaceutical and small biotech and research institutes on drug discovery. He is also a member of the Industrial Advisory Board for the EU-OpenScreen organisation.
Prior to his current position, Professor Everett held a variety of drug discovery technology leadership positions at Pfizer, and before that, SmithKline Beecham and Beecham Research Laboratories. These positions included responsibilities for analytical sciences, automated purification, biobanking, chemoinformatics, computational chemistry, ligand-based drug design, curation, management and provision of the compound screening file, data support and management, lead generation by high throughput screening, compound library design and production, indications discovery, structural biology, structure-based drug design and drug target analysis.
Professor Everett received both his BSc in chemistry and PhD in physical organic chemistry from Nottingham University. He was a Post-doctoral Fellow at McMaster University in Hamilton, Ontario, and a Research Associate at McGill University, Montréal.